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ARTICLE
Structural insights into chaperone addiction
of toxin-antitoxin systems
Valérie Guillet1, Patricia Bordes2, Cécile Bon1, Julien Marcoux 1, Virginie Gervais1, Ambre Julie Sala2,
Suzana Dos Reis1, Nawel Slama2, Israel Mares-Mejía1, Anne-Marie Cirinesi2, Laurent Maveyraud 1,
Pierre Genevaux2 & Lionel Mourey 1
SecB chaperones assist protein export by binding both unfolded proteins and the SecA motor.
Certain SecB homologs can also control toxin-antitoxin (TA) systems known to modulate
bacterial growth in response to stress. In such TA-chaperone (TAC) systems, SecB assists
the folding and prevents degradation of the antitoxin, thus facilitating toxin inhibition. Cha-
perone dependency is conferred by a C-terminal extension in the antitoxin known as cha-
perone addiction (ChAD) sequence, which makes the antitoxin aggregation-prone and
prevents toxin inhibition. Using TAC of Mycobacterium tuberculosis, we present the structure
of a SecB-like chaperone bound to its ChAD peptide. We find differences in the binding
interfaces when compared to SecB–SecA or SecB-preprotein complexes, and show that the
antitoxin can reach a functional form while bound to the chaperone. This work reveals how
chaperones can use discrete surface binding regions to accommodate different clients or
partners and thereby expand their substrate repertoire and functions.
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Universally conserved molecular chaperone machinesmaintain cellular protein homeostasis by preventingprotein misfolding and aggregation, off-pathways in
protein biogenesis. In bacteria, the ATP-independent homo-
tetrameric chaperone SecB (69 kDa) assists protein export by
binding to presecretory proteins and delivering them post-
translationally to the Sec translocon at the inner membrane1.
SecB binds its preprotein clients in a one to one ratio and
maintains them in nonnative translocation competent state,
protected from premature folding and recognition by cytosolic
proteases2. Although SecB has no apparent specificity for signal
sequences, in vitro peptide scan analysis revealed preferences for
stretches of nine amino acids enriched in aromatic and basic
residues present in protein clients3,4. SecB can accommodate long
fragments of up to 150 amino acids in length within polypeptide
substrates5. The recently determined nuclear magnetic resonance
(NMR) structures of SecB bound to its full-length native sub-
strates maltose-binding protein (MBP) and alkaline phosphatase
(PhoA) confirmed that SecB possesses a remarkably large
substrate-binding surface (about 7600 Å2) where the client pro-
tein wraps all around the chaperone in an unfolded conforma-
tion, occupying the entire SecB substrate-binding surface6.
In addition to its preprotein clients, SecB specifically interacts
with SecA, the essential ATPase motor subunit of the Sec trans-
locon7. Upon interaction, SecB passes on its client to SecA, which
subsequently promotes preprotein translocation through the
SecYEG pore. SecA-SecB interaction mainly involves the C-
terminal zinc-binding region of SecA and the negatively charged
surface formed by the β-sheets on both sides of the SecB tetra-
mer8. However, additional contacts between the C-terminal helix
of SecB and the N-terminal region of SecA have been found9.
Although the substrate transfer mechanism remains unknown,
the surfaces of SecB that interact with the preprotein and with
SecA overlap significantly, thus likely facilitating substrate
transfer from the chaperone to the translocase.
Besides the generic role of SecB in protein export, SecB
homologs are frequently associated (in about 7% of cases) with
stress-responsive type II toxin–antitoxin (TA) systems, together
forming functional tripartite TA-chaperone (TAC) systems10.
Classical type II TA systems are small genetic modules encoding
two cytosolic proteins: a poisonous toxin and a less stable and
protease-sensitive cognate antitoxin, which binds and inhibits
the toxin. Under normal growth conditions, the antitoxin-bound
toxin is inactive and the bacteria grow normally. It is believed
that under certain stress conditions the less stable antitoxin is
degraded by proteases and that the resulting free active toxin
targets essential cellular processes such as protein synthesis or
DNA replication, thus inhibiting growth until normal growth
conditions resume11,12. TA systems are also widely distributed
on mobile genetic elements, including plasmids, where they
contribute to their stability. In this case, when the TA-containing
plasmid is lost, de novo synthesis of the antitoxin stops and the
reservoir of cytosolic antitoxin is rapidly degraded, which results
in toxin activation and cell growth inhibition13. Control of
bacterial growth by toxins has been associated with various
cellular processes, including stabilization of genomic regions,
protection against foreign DNA, biofilm formation, control of
the stress response, bacterial virulence and persistence14,15.
Although an involvement of TA systems in persistence was
found for several bacteria16–19 their contribution to Escherichia
coli K-12 drug persisters has not been demonstrated20,21. In
tripartite TAC systems, the SecB chaperone encoded within the
same operon as the TA genes, directly interacts with the highly
unstable TAC antitoxin and prevents its aggregation and
degradation, thus facilitating subsequent inhibition of the
toxin22.
The human pathogen Mycobacterium tuberculosis possesses
such a TA-associated SecB chaperone, namedMtb-SecBTA, which
specifically controls the Mtb-HigB1 (toxin)-HigA1 (antitoxin) TA
pair12,22. Mtb-HigB1, which likely belongs to the RelE toxin
superfamily of ribonucleases, was shown to severely inhibit E. coli,
M. smegmatis, M. marinum, and M. tuberculosis growth12.
Noticeably, Mtb-TAC genes were shown to be significantly
induced in response to several stresses relevant forM. tuberculosis
pathogenesis. This includes DNA damage23, heat shock24,
nutrient starvation25, hypoxia26, host phagocytes27 and
antibiotic-induced persistence28, suggesting that the TAC system
could contribute to the stress adaptive response and/or to the
virulence of this bacterium. Yet, such a role for TAC remains to
be demonstrated.
We have recently shown that in contrast with chaperone-
independent TA systems, the Mtb-HigA1 antitoxin of TAC
possesses a C-terminal extension, named ChAD (chaperone
addiction), which makes the antitoxin more aggregation-prone
and renders it chaperone-dependent. In this case, the ChAD
extension is specifically recognized by theMtb-SecBTA chaperone,
which protects it from both aggregation and degradation29.
In this work, we provide biochemical and structural insights
into the mechanism of chaperone addiction. Using TAC of M.
tuberculosis as model system, we solved the crystal structure, at
high resolution, of a TA-associated SecB chaperone bound to the
ChAD peptide of its cognate antitoxin. The structure reveals
major differences in binding mode and substrate occupancy when
compared to SecB–SecA or SecB–substrate complexes. Further
extensive mutagenesis of contact surface residues revealed several
previously unidentified residues essential for TA-control by Mtb-
SecBTA chaperone in vivo. Finally, we showed that the antitoxin
can reach a functional form while bound to the chaperone and
that ChAD peptide may efficiently destabilize the interface
between the antitoxin and the chaperone in vitro and specifically
activate the Mtb-HigB1 toxin in vivo.
Results
Three-dimensional structure of Mtb-SecBTA in complex with
ChAD. In contrast with the classical export chaperone SecB,
which binds and wraps unfolded presecretory protein substrates
and maintains them in an unfolded conformation compatible
with translocation through membrane6, previous work revealed
that the Mtb-SecBTA chaperone of TAC is capable of binding to
its aggregation-prone Mtb-HigA1 antitoxin substrate to facilitate,
and thus not prevent, its folding in the cytosolic space. This
strongly suggests a different binding mode of SecB-like chaper-
ones with their antitoxin clients. To investigate the SecB
substrate-binding property, we have solved the structure of Mtb-
SecBTA together with the short C-terminal fragment of the Mtb-
HigA1 antitoxin (named ChAD), which was found as the main
site of interaction with the chaperone, both in vivo and
in vitro29,30. The structure comprises a Mtb-SecBTA homo-
tetramer (the subunits, termed A–D, contain 136–138 residues of
the 181 amino acids found in theMtb-SecBTA sequence) to which
three ChAD peptides (corresponding to sequence
104EVPTWHRLSSYRG116 of Mtb-HigA1 named C4 in a previous
study29; subunits E–G), 2 dimethyl sulfoxide (DMSO) molecules,
and 3 Ca2+ ions are bound (Table 1 and Fig. 1a). The Mtb-
SecBTA structure resembles that of SecB for which four structures
have been solved: the X-ray structures of Haemophilus influenzae
SecB alone31 and in complex with the C-terminal 27 residues of
SecA8, the X-ray structure of E. coli SecB alone32, and the NMR
structures of its complexes with alkaline phosphatase and
maltose-binding protein in their unfolded states6 (Supplementary
Fig. 1a). The three-dimensional fold of Mtb-SecBTA consists of a
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six-residue long N-terminal helix (αN) followed by a four-
stranded antiparallel β-sheet (β1–β4), each strand contributing
13–16 residues, and a 30-residue long C-terminal helix (α1) that
is prolonged by an extended peptide segment running parallel to
α1 (Fig. 1b and Supplementary Fig. 1b). Missing residues are
found in the majority at the N and C termini (5–12 and 15–19
residues missing, respectively) and in the loop between β3 and β4
(13–16 residues missing), in all subunits. The superposition of the
subunits making up the Mtb-SecBTA tetramer led to a root mean
square deviation (rmsd) of Cα atoms ranging between 0.4 (sub-
unit C vs. B) and 1.2 Å (subunit C vs. A). This is in line with the
NMR characterization of SecB, which revealed two pairs of
spectroscopically equivalent subunits formed on the one hand by
subunits A and D and on the other hand by subunits B and C6.
Largest deviations correspond to spatial locations lining regions
with missing residues, which in turn correlates with high B-
factors, thus indicating structural flexibility.
The Mtb-SecBTA tetramer consists of a dimer of dimers as
already described for SecB31,32. Two subunits associate through
their β1 strands to form β-dimers (A–B and C–D), resulting in an
eight-stranded antiparallel β-sheet (Fig. 1a). In the tetramer, the
A–B and C–D β-dimers are stacked up through their helices α1 at
an angle of ca. 45° (Fig. 1a). The dimer and dimer–dimer
interface areas are in the same range: 739/728 Å2 for A–B/C–D vs.
820/704 Å2 for A–C/B–D (Supplementary Table 1). It is
noteworthy that the tetramer displays internal dihedral (D2)
symmetry that includes three perpendicular twofold symmetry
axes. However, not all among the three possible superimpositions
through rotations around these axes are equivalent. Only one
permutation (DCBA) gives a rmsd value of 0.6 Å after super-
posing 522 Cα atoms to the reference tetramer (ABCD), whereas
the two others (BADC and CDAB) led to much higher rmsd
values of 3.5 Å. The DCBA permutation is generated through
rotation around the twofold axis that lies between the
dimer–dimer interface and runs nearly perpendicular to helices
α1 (Fig. 1a). This distorted dihedral symmetry is also found in the
previously determined SecB structures (PDB entries 1FX3, 1OZB,
1QYN, and 5JTL), but has never been described before. Molecular
dynamics calculations performed on the structure suggest that
this distorted arrangement is stable over the 60-ns simulation
time, and that once trapped into such a conformation, no further
fluctuation does occur (Supplementary Fig. 2a).
It has recently been reported that diffraction-quality crystals of
Mtb-SecBTA could only be grown at high concentrations of
DMSO. Indeed, the use of DMSO improved initial needle-like
crystals but was not sufficient to resolve the structure33. Adding
5–10% DMSO in the protein and/or crystallization buffer played
a role with respect to nucleation but did not markedly influence
the diffraction limit of Mtb-SecBTA/ChAD crystals. We also
noted that the presence of calcium ions was important for the
crystallization of the complex. Three Ca2+ ions were localized
based on electronic density and geometric criteria, and calcium
binding occurs in subunits A, B, and D at the same position
(Fig. 1a). Indeed, all three ions interact with main-chain nitrogen
atom and side-chain oxygen atom of S65, with the main-chain
oxygen atom of Y111, and with the carboxylate of D110 thereby
linking the N- and C-termini of strands β3 and β4, respectively.
The lack of calcium binding to subunit C is due to crystal packing
constraint where loop β4-α1 of a symmetry mate partly occupies
the site.
Comparison of Mtb-SecBTA and SecB structures. Pairwise
comparison of the Mtb-SecBTA crystallographic tertiary structure
with those of Hi-SecB and Ec-SecB gave rmsd values around 2.0 Å
for about 110 Cα atoms of residues sharing 15% identity. In
comparison, superimposition of the Hi- and Ec-SecB subunits led
to rmsd values less than 1.0 Å for ca. 130 residues sharing 59%
identity. There are three major differences between the Mtb-
SecBTA tertiary structure and its SecB counterparts (Fig. 1b and
Supplementary Fig. 1b): (i) Mtb-SecBTA has a longer N terminus
that adopts a helical fold (αN), (ii) it has a 12- to 14-residue long
insertion in the loop between β3 and β4, which is disordered in
the structure, and (iii) its C terminus is shorter and could not be
traced beyond residue number 164. In contrast, the C-terminal
ends of Hi- and Ec-SecB are better defined in density where they
form helix α2. We verified by mass spectrometry (MS) of dis-
solved crystals that no proteolytic cleavage, which could account
for the missing C-terminal residues, had occurred in the crys-
talline state. Structural dynamics might then be responsible for
the absence of electron density for the C-terminal residues of
Table 1 Crystallographic data collection and refinement
statistics
Mtb-SecBTA/HigA1(104–116)
PDB code 5MTW
Data collection
Diffraction source ESRF ID29
Space group P212121
Unit cell a, b, c (Å) 86.86, 89.96, 91.34
Unit cell α, β, γ (°) 90.00, 90.00, 90.00
Resolution range (Å) 64.09–1.835 (1.867–1.835)a
No. of unique reflections 63,188 (3135)
Completeness (%) 99.9 (99.6)
Redundancy 6.5 (6.7)
〈I/σI〉 13.7 (2.3)
Rmerge 0.093 (0.796)
CC1/2 0.999 (0.338)
Refinement
Resolution range (Å) 64.09–1.835 (1.883–1.835)a
No. of reflections (work/test) 59,790/3397 (4325/275)
No. of molecules/AUb 1 Mtb-SecBTA tetramer+ 3 bound Mtb-
HigA1(104–116) peptides
Rwork/Rfree 0.212/0.265 (0.330/0.354)
Chain/no. of residues/missing
residues
A/138/1–8, 43–44, 82–96, 164–181
B/138/1–5, 43–46, 81–96, 164–181
C/138/1–12, 82–94, 114–116, 167–181
D/136/1–9, 81–95, 114–115, 163–181
E/12/116
F/12/116
G/12/116
No. of nonhydrogen atoms
All atoms 4660
Protein atoms 4282
Peptide atoms 318
Other ligands 8
Ions 3
Water molecules 49
Average B-factors (Å2)
All atoms 34.7
Protein atoms 34.3
Peptide atoms 39.7
Other ligands 63.5
Ions 45.7
Water molecules 32.6
RMS deviations
Bond lengths (Å) 0.019
Bond angles (°) 1.941
Ramachandran plot (%)
Most favored regions 93.9
Allowed/disallowed 6.1/0.0
aValues in brackets are for the highest-resolution shell.
bAsymmetric unit.
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Mtb-SecBTA and the location of a C-terminal α2 helix as found in
Hi- and Ec-SecB. Such flexibility might be fostered by the prox-
imal location of the N-terminal helix, whose position is dictated
for some of the subunits by crystal packing constraints, and which
otherwise would induce steric clashes (Supplementary Fig. 1b).
Other differences between the Mtb-SecBTA and SecB structures
occur in loops β1–β2, β2–β3, and β4–α1 (Fig. 1b and Supple-
mentary Fig. 1). Superimposing the crystal structure of Mtb-
SecBTA tetramer with those of Ec- and Hi-SecB gave rmsd values
around 2.0 Å. In comparison, superposing the Ec- and Hi-SecB
tetramers led to rmsd values of 0.9 Å. Although the tetramers are
highly similar in structure, important variations were found when
comparing the dimer and dimer-dimer interface areas (Supple-
mentary Table 1). Whether these structural differences are
important for TA control, export function or protein stability is
unclear. The fact that all the TAC chaperones tested so far could
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efficiently replace Ec-SecB export function, regardless of the
sequence similarities10,29, and that single-point mutations in
substrate-binding area were sufficient to redirect Ec-SecB toward
Mtb-HigBA1 without affecting its function in protein export30,
suggest that such differences may not be critical for TA control or
export.
Mtb-SecBTA and related Ec- and Hi-SecB are acidic proteins
that remarkably share a strictly identical theoretical pI value of
4.3. In accordance, analysis of the topography and charge
distribution revealed that they display very electronegative
molecular surfaces but differences between the SecB proteins
and Mtb-SecBTA are noticeable (Supplementary Fig. 3). Major
differences pertain in fact to negative charge distribution. For
instance, there is a strong electronegative cluster right in the
middle of the SecB eight-stranded β-sheet, which arises from side-
chain clustering of residues D20/D27, E24/E31, and E77/E86 (Ec-
SecB/Hi-SecB numbering), which is important for interaction
with SecA C-terminal region. In Mtb-SecBTA, these residues are
replaced by R32, A36, and D102, respectively. The fact that Mtb-
SecBTA is less efficient than Ec-SecB when tested for SecA-
dependent function in E. coli suggests that such modified
electrostatic interface might be responsible for the reduced
complementation in vivo.
Another important difference is found in a groove delineated
by the N-terminus of strand β1, the β1–β2 loop, helix α1, and the
extended C-terminal segment. This groove is neutral or slightly
positively charged in SecB whereas it is electronegative in Mtb-
SecBTA, involving the D27, E143, and D147 residues and the
positively charged R151. In contrast, only one acidic residue is
found in SecB, E112/E121, which corresponds to E143 of Mtb-
SecBTA, and is counterbalanced by R120/R129 equivalent to R151
in Mtb-SecBTA.
Mtb-SecBTA/ChAD interaction. In order to investigate how the
chaperone specifically recognizes the C-terminal chaperone-
addiction region of the Mtb-HigA1 antitoxin, key residues
involved in the interaction between the ChAD peptide (Mtb-
HigA1 104EVPTWHRLSSYRG116) and the Mtb-SecBTA chaper-
one substrate-binding surface were analyzed in detail. Note that
this small peptide represents the main region of the ChAD
extension of Mtb-HigA1 that is recognized by the chaperone,
both in vivo and in vitro29. In the structure, there are three bound
ChAD peptides (chains E–G) per tetramer (Fig. 2a). For all three
peptides, there was no adequate electron density to build the last
residue (G116) and the side chain of R115 is also missing in
peptide G (Supplementary Fig. 4). Binding occurs on the thinner
side of the Mtb-SecBTA chaperone tetramer. On one side, two
peptides (chains E and F) are bound in a symmetrical way
(related by a twofold axis) and adopt strictly the same extended
conformation with a rmsd of 0.6 Å based on main-chain atoms.
The third peptide (chain G) binds on the opposite side and also
adopts an extended conformation identical from residues
104–108 (rmsd of 0.5 Å on backbone atoms) but differs in main-
chain (φ,ψ) angles from residues 109–114 (rmsd of 2.1 Å). It is
noteworthy that peptide G differs in conformation from peptides
E and F to conserve the same type of interactions with the pro-
tein, and molecular dynamics (MD) calculations indicate that
such binding mode is preserved during the 60 ns of simulation
(Supplementary Fig. 2b). On the other hand, no sufficient inter-
pretable electron density could allow the building of a symme-
trical equivalent of peptide G (Supplementary Fig. 4), which
because of steric clashes due to the distorted D2 symmetry would
not be possible without structural rearrangement. Each bound
peptide makes contact with three protein subunits in a similar
way, with some variations (Fig. 1c). A residue-per-residue
detailed description of the interactions is given in Supplemen-
tary Table 2.
In agreement with previous in vivo data29,30, the structure
reveals that three ChAD residues play a major structural role in
complex formation, namely W108, R110, and Y114. Mtb-HigA1
(W108) makes strong interactions with the protein (Fig. 2b). It is
involved in hydrogen bonding with D27 located on strand β1. In
addition, its indol ring is completely buried in a protein cavity
delineated by residues D27, R29, V68, and L108, from one Mtb-
SecBTA subunit, and A153 (at the C terminus of α1) from another
Mtb-SecBTA subunit. It is also involved in cation-π interactions
with R29 side chain. Mtb-HigA1(R110) makes strong polar
interactions with D27 and I28 from one subunit, and with G150
(at the C terminus of α1) from another subunit (Fig. 2b). van der
Waals interactions with a third protein subunit also contributes to
the steady anchoring of Mtb-HigA1(R110). Mtb-HigA1(Y114) is
hydrogen bonded to the protein through interaction with P155.
In addition, its phenol group perfectly fits a gorge delineated by
residues L47, Y49, L154, P155, P156, and L157 (Fig. 2c).
Mutagenesis of Mtb-SecBTA residues involved in ChAD bind-
ing. In order to investigate whether the interaction between Mtb-
SecBTA and the antitoxin was relevant in vivo, all residues ofMtb-
SecBTA involved in polar interactions with the ChAD peptide,
either through side-chain or main-chain atoms, and those
involved in nonbonding interactions through burying more
than 50% of their solvent accessible surface (Fig. 1b and Sup-
plementary Table 2) were systematically mutated to alanine
residues. The resulting variants were then tested for both their
Fig. 1 Overall structure of the Mtb-SecBTA/ChAD complex and determinants of SecB ligand specificity. a The A–D subunits forming the Mtb-SecBTA
tetramer are respectively colored in green, orange, violet, and yellow whereas ChAD peptides (chains E–G) are in slate blue. Calcium ions are shown as
green spheres. DMSO molecules (labeled DMS) are shown as a stick representation. Left and right views are separated by a 90° rotation around a vertical
axis. Secondary structures have been labeled for the A–B (left) and A–C (right) dimers. b Structure-based sequence alignment. Sequence similarity is
indicated by red letters, whereas sequence identity is indicated by white letters on a red background. Aligned and unaligned residues are displayed in
uppercase and lowercase, respectively, taking Mtb-SecBTA as reference. Secondary structure elements as deduced from the crystal structures of Mtb-
SecBTA/ChAD, Ec-SecB (PDB code 1QYN), and Hi-SecB (1FX3) are indicated. Residues absent from the structures are on a green background. Residues
involved in protein–protein interface of the Mtb-SecBTA/ChAD, Ec-SecB/PhoA (5JTL), and Hi-SecB/SecAc (1OZB) complexes are indicated by symbols:
solid ellipses and triangles, residues involved in polar interactions through side-chain and main-chain atoms, respectively; stars, residues having ≥50% of
their surface area buried upon van der Waals interactions. For Mtb-SecBTA, color coding of the symbols is according to the impact of alanine scanning on
the ability to maintain TA control from green (no effect) to orange (medium effect) to red (most severe effect). Residues that were not tested (i.e., Ala
residues and Y146, which was too strongly expressed) are designated by unfilled symbols. The V40A/L42A/L44A triple substitution that causes a 40-fold
reduction in the affinity of Ec-SecB for PhoA is in purple. c Sequence of the Mtb-HigA1 ChAD peptide. The rectangles below the sequence represent the
amino acids that have been changed for alanine as previously reported29. Green rectangles represent mutations without apparent phenotype with respect
to their chaperone dependence in vivo; orange, mutations with partial inactivation; red rectangles, mutations with the most severe phenotype. Interfacing
residues with Mtb-SecBTA are depicted using the same symbol scheme as in a
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Fig. 2 ChAD binding on Mtb-SecBTA. a Molecular surface of the tetramer. The three bound peptides are shown as a stick representation with carbon,
nitrogen, and oxygen atoms in slate blue, blue, and red, respectively. The protein and peptide chains as well as ChAD residues have been labeled. Left and
right views are separated by a 180° rotation around a vertical axis. b Close-up view centered on ChAD residues W108 and R110. c Close-up view centered
on ChAD residue Y114. In b and c, Mtb-SecBTA atoms found within 5 Å of the peptides are shown as enlarged sticks and depict the ChAD-binding site
shown as a semitransparent surface. Polar interactions are represented by black dotted lines. Views on the left (resp. right) are for subunit F (resp. G).
Color coding of interacting residues is the same as in Fig. 1b
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ability to control the toxin (Fig. 3) and to functionally replace the
canonical E. coli export chaperone SecB with respect to its generic
chaperone function at low temperature and in the presence of
novobiocin antibiotic34,35 (Supplementary Fig. 5). Steady state
expression of the Mtb-SecBTA derivatives revealed that all
mutants are well expressed when compared to the wild type
(Supplementary Fig. 6). Mtb-SecBTA mutations that most sig-
nificantly affect TA control were found at positions making
strong interactions with ChAD residues shown to be involved in
chaperone binding29, namely residues D27, R29, and L108
interacting with Mtb-HigA1(W108), and residues Y49, I77, L154,
P155, P156, L157 interacting with Mtb-HigA1(Y114) (Fig. 2b, c).
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Fig. 3 In vivo functions of TA-directed Mtb-SecBTA mutants. a Suppression of Mtb-HigBA1 toxicity by Mtb-SecBTA mutants. E. coli W3110 ΔsecB
transformants containing the p29SEN-based Mtb-SecBTA chaperone mutants and pK6-Mtb-HigBA1 were grown to mid-log phase, serially diluted and
spotted on LB ampicillin kanamycin agar plates with or without IPTG (to express Mtb-SecBTA) and arabinose (to express Mtb-HigBA1) as indicated. Plates
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It is noteworthy that Mtb-HigA1(G116), whose mutation to
alanine was also associated to a defect in vivo29, could not be
resolved in the electron density. Moreover, residues D27 and
L154 of Mtb-SecBTA are also involved in interactions with R110
ofMtb-HigA1 (Fig. 2b). Two otherMtb-SecBTA residues, L47 and
F67, appeared to be important in vivo. Although not directly
interacting with Mtb-HigA1(Y114), L47 contributes to the pocket
that accommodates the tyrosine phenol ring (Fig. 2c). The role
played by F67 seems to be more structural since the phenylala-
nine ring is oriented toward the interior of the protein thereby
contributing to a network of hydrophobic/aromatic interactions.
The mutation for an alanine might locally destabilize the protein
hydrophobic core and in turn the positioning of strand β3
backbone, which is involved in ChAD interaction. Noticeably,
although spread all over the sequence, essential residues of Mtb-
SecBTA involved in the interaction with ChAD define two major
binding spots when mapped on the 3D structure (Fig. 1). The first
spot is located on the β-sheet of one of the four tetramer subunits,
and involves strands β1–β3. The second spot, which comprises
the residues most severely affected by mutations, is found on the
protomer of the adjacent β-dimer. It involves the N-terminal tip
of strand β2 and residues that follow helix α1 and form the helix
connecting loop. Such crosslinking of ChAD peptides at the
surface of the Mtb-SecBTA tetramer might tighten, or even lock,
the dimer–dimer interface and explain the improvement found in
both diffraction quality and resolution of the crystals of the Mtb-
SecBTA/ChAD complex vs. those of Mtb-SecBTA.
All the Mtb-SecBTA mutations that most significantly impaired
TA control additionally affected the ability to replace the E. coli
export chaperone SecB in vivo at low temperature of growth, with
the exception of Y49A (Supplementary Fig. 5). Remarkably, Y49A
significantly improved Mtb-SecBTA ability to replace Ec-SecB
in vivo. Two other mutations, G46A and D58A, slightly improved
Mtb-SecBTA chaperone generic function but, in contrast with
Y49A, without affecting TA control. These three residues are
spread along strand β2, G46, and Y49 close to each other at the
N-terminal side and D58 at the C terminus. It is noteworthy that
Mtb-SecBTA(Y49) corresponds to Ec-SecB(V40) whose mutation
as part of the triple amino-acid substitution V40A/L42A/L44A
(with all three residues on β2) was shown to cause a 40-fold
reduction in the affinity of Ec-SecB for PhoA6. Whether these
mutations affect SecB substrate-binding specificity or its interac-
tion with its SecA partner is not known.
Specific affinity of ChAD for Mtb-SecBTA chaperone. Several
approaches were used to characterize complex formation between
Mtb-SecBTA and the ChAD peptide in solution and to further
confirm structure-function relationships deduced from the X-ray
structure and mutagenesis experiments. Isothermal titration
calorimetry (ITC), performed under both direct and reverse
conditions, and microscale thermophoresis (MST) showed that
the chaperone interacts with the ChAD peptide with moderate
affinity, with a Kd dissociation constant of 1.9 ± 0.2 and 2.6 ± 0.6
µM, respectively (Fig. 4a, b). The ITC-derived thermodynamic
parameters indicated an enthalpy-driven mode (−50.1 kJ mol−1)
accompanied with an entropic penalty (−TΔS= 18.7 kJ mol−1),
likely suggesting formation of hydrogen bonds associated with
binding, which is in line with the crystal structure. On the other
hand, the stoichiometry obtained by direct and reverse ITC for
this specific association is 0.47 and 2.2, respectively, consistent
with a model preferentially involving two peptides per Mtb-
SecBTA tetramer. Extensive small-angle X-ray scattering (SAXS)
analysis performed on different protein preparations system-
atically revealed that the scattering curves corresponding to Mtb-
SecBTA and Mtb-SecBTA/ChAD peptide displayed small but
significant differences (Fig. 4c). Both Guinier and the
concentration-independent method36 were applied to SAXS data
and gave respective molecular weight of 84.5 ± 0.1, 81.7 ± 0.4 kDa
for Mtb-SecBTA and 89.7 ± 0.1, 83.6 ± 0.3 kDa for Mtb-SecBTA/
ChAD. The chaperone alone and its complex with ChAD form
well folded molecular species, as can be observed from normalized
Kratky plots (Fig. 4c, inset), and Guinier analysis gave Rg values of
3.17 ± 0.02 and 3.02 ± 0.02 nm and maximum dimensions of the
particles (Dmax) of 9.5 ± 0.2 and 8.8 ± 0.2 nm, respectively. This
indicates that, at the resolution probed, Mtb-SecBTA does not
undergo a major conformational change upon ChAD peptide
binding but rather displays a slight compaction and a less dynamic
behavior. These properties might be related to the better dif-
fracting quality of the crystals obtained in the presence of the
peptide. In addition, the scattering curve calculated from the Mtb-
SecBTA/ChAD peptide crystal structure, where the missing loops
representing 24% of the unbuilt residues have been modeled, led
to a rather good, albeit not perfect, agreement (χ= 2.6) with
experimental data (Fig. 4c). To further investigate the dynamic
behavior of the chaperone, we performed Hydrogen–Deuterium
eXchange MS (HDX-MS) on Mtb-SecBTA alone and in the pre-
sence of ChAD peptide. The kinetics of exchange for Mtb-SecBTA
alone revealed some highly dynamic and/or accessible regions
(namely residues 13–18, 37–51, 59–67, and 161–181, in line with
the absence of electron density for the C-terminal residues ofMtb-
SecBTA) compared to more protected regions (residues 68–75,
98–108, and 124–152). Interestingly, a large decrease in deutera-
tion upon binding of the ChAD peptide was observed for residues
21–27 and 153–159, which are precisely located along the peptide-
binding pocket, and juxtaposing residues 52–57 (Supplementary
Fig. 7a). These results also confirm that the chaperone is rather
stable upon complex formation with ChAD.
The deconvoluted MS spectrum obtained for Mtb-SecBTA under
nondenaturing conditions clearly showed the presence of a tetramer
at 81,575 Da and up to 7 additional species, separated by 1587 Da,
progressively appearing upon titration with the ChAD peptide
(Fig. 4d and Supplementary Fig. 8a). Binding of the first four
peptides to the tetrameric chaperone corresponds to relatively high-
affinity events, as they occur at small peptide:tetramer ratios (<4),
whereas binding of the three additional peptides only occurred at
high molar ratios (>4), probably due to nonspecific interactions
(Supplementary Fig. 8a). Plotting the relative abundance obtained
for each species at increasing molar ratios and fitting the
corresponding curves (Supplementary Fig. 8b) confirmed this
observation, with Kd values in the range 6–17 µM. Incubation of the
chaperone with 8 molar equivalents of 13-mer peptides, which also
belong to the ChAD sequence but do not contain the main
chaperone-binding determinants29, only showed limited binding to
the tetramer, confirming the higher binding specificity observed for
the ChAD peptide (Fig. 4e). This low-abundance interaction may be
related to some non-specific binding also observed at high molar
ratios of ChAD peptide. The nonspecific adduction is a common
feature of native MS when working with substrate/ligand
concentrations greater than 50 µM37.
Full-length Mtb-SecBTA/HigA1 chaperone/antitoxin complex.
Multiple attempts to crystallize the full-length Mtb-SecBTA/
HigA1 complex were unsuccessful, although such complex could
be easily purified in a stable soluble form. Size exclusion chro-
matography and multi-angle light scattering (SEC-MALS) clearly
indicated that Mtb-SecBTA alone primarily forms tetramers while
experiments performed on Mtb-SecBTA co-expressed with Mtb-
HigA1 revealed a single-molecular species representing a 4:2
chaperone/antitoxin stoichiometry (Fig. 5a). These results were
further confirmed by native MS (114.9 kDa, see next paragraph).
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In addition, we found that under the same experimental in vitro
condition, purified Mtb-HigA1ΔC42 mutant, which was shown to
be fully soluble and functional in vivo in the absence of chaper-
one29, was isolated as a dimer (Fig. 5a), as observed with known
chaperone-independent HigA antitoxins38,39. SAXS was also used
to characterize full-length Mtb-SecBTA/HigA1. The correspond-
ing scattering curve is significantly distinct from those obtained
for Mtb-SecBTA alone or in complex with the peptide and reflects
a well folded protein/protein complex (Fig. 4c) of molecular
weight 114.4 ± 0.1 and 120.0 ± 0.3 kDa as obtained from Guinier
and concentration-independent methods, respectively, and with
Rg and Dmax values of respectively 3.61 ± 0.02 and 12.0 ± 0.2 nm.
Finally, we performed HDX-MS on the Mtb-SecBTA/HigA1
complex. Strikingly, binding of the chaperone to Mtb-HigA1
client resulted in the protection of the same stretches of residues
as for Mtb-SecBTA/ChAD with the addition of residues 48–51
and 59–66, which are located in the continuity of the peptide-
binding pocket (Supplementary Fig. 7b). This observation sug-
gests a significantly larger binding interface between the chaper-
one and full-length Mtb-HigA1 when compared to the short
ChAD peptide. We also did not find any specific destabilization of
Mtb-SecBTA upon complex formation with Mtb-HigA1, which is
in agreement with the Kratky analysis of the SAXS data.
As observed for most type II DNA binding antitoxins, Mtb-
HigA1 can act as a repressor of its own Mtb-higBA1 operon40. In
order to further investigate the activity of soluble dimeric Mtb-
HigA1 bound to Mtb-SecBTA tetramers, we have used SEC-
MALS, native MS, and ITC to monitor the interaction between
the purified Mtb-SecBTA/HigA1 complex and dsDNA using a 38-
bp palindromic sequence derived from the higB P2 promoter.
First, we found that Mtb-SecBTA alone does not interact with the
38-bp dsDNA sequence. In contrast, SEC-MALS experiments
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demonstrated that Mtb-SecBTA/HigA1 forms a single stable
molecular species in the presence of DNA, most likely
corresponding to 4:2:1 Mtb-SecBTA/HigA1/DNA stoichiometry
(Fig. 5a), with a shift in the hydrodynamic radius from 4.4 to 5.0
nm upon DNA binding. We verified by SEC-MALS that no
interaction occurs between Mtb-SecBTA/HigA1 and a nonspecific
dsDNA such as a 16-bp oligonucleotide derived from the RRM1
promoter41. We also used native MS to analyze Mtb-SecBTA/
HigA1 in complex with its specific DNA target and observed that
they indeed form a 4:2:1 complex of molecular weight 138.25 kDa
(Supplementary Fig. 9a). In addition, ITC experiments showed
that the higB P2 promoter DNA fragment interacts with the
hexamer with a high affinity (2.2 ± 0.5 × 107 M−1 at 25 °C)
(Fig. 5b). The ITC-derived thermodynamic parameters indicated
M
ol
ar
 m
as
s 
(g
.m
ol
–1
)
1 × 105
2 × 105
3 × 105
4 × 105
0.0
0.2
0.4
0.6
0.8
1.0
N
or
m
al
iz
ed
 d
R
I
0 2 4 6 8
Time (min)
Mtb-SecBTA/HigA1: 117,300
Mtb-SecBTA: 82,400
Mtb-HigA1ΔC42: 30,400
Mtb-SecBTA/HigA1/DNA: 136,800
Time (min)
0.0 2.01.51.00.5
Molar ratio
–1.05
0.00
–0.21
–0.42
–0.63
–0.84
μW
-25.12
-20.93
–16.75
–12.56
–8.37
–4.19
0.00
–1.26
-29.31
R
el
at
iv
e 
ab
un
da
nc
e
0 1 2 4 16
0
10
20
30
40
50
60
70
80
90
0.5%
Ara
–
– 4 nM ATc
250 μM IPTG
PBAD Mtb-HigBA1
PTet Mtb-SecBTA
Ptrc Luciferase ± ChAD
kJ
 m
ol
–1
 o
f i
nj
ec
ta
nt
0 10 20 30 40 50 60
ChAD:Mtb-SecBTA/HigA1 molar ratio
–– Lu
c
Lu
c-
Ch
AD
Lu
c-
Ch
AD
Y1
14
A
Lu
c
Lu
c-
Ch
AD
Lu
c-
Ch
AD
Y1
14
A
a c
b d
Fig. 5 Characterization of full-length Mtb-SecBTA/HigA1 chaperone/antitoxin complex. a SEC-MALS analysis. Continuous and dashed lines represent the
variation of refractive index against elution time forMtb-SecBTA (red),Mtb-SecBTA/HigA1 (blue),Mtb-HigA1ΔC42 (violet), andMtb-SecBTA/HigA1/dsDNA
(black) for protein and salt contributions, respectively. The experimentally measured molar mass distribution (same color code) and deduced mean molar
mass (in g mol−1) are indicated for each elution peak. Calculated molecular masses of proteins and protein complexes used for experiments (in daltons):
Mtb-SecBTA tetramer, 81,552; Mtb-SecBTA/HigA1 hetero-hexamer, 115,068; Mtb-HigA1ΔC42 dimer, 27,994; Mtb-SecBTA/HigA1/dsDNA, 138,420. b ITC
profile of 38-bp dsDNA titrated into Mtb-SecBTA/HigA1 (upper and lower parts represent raw and integrated binding heats, respectively). c Native MS-
derived relative abundance of Mtb-SecBTA/HigA1 (blue bars) and Mtb-SecBTA (red bars) obtained upon titration of Mtb-SecBTA/HigA1 with 0, 1, 2, 4, 16
molar equivalents of ChAD. d Overexpression of luciferase-ChAD chimera activates Mtb-HigB1. E. coli WPtet57 strain expressing chromosomally encoded
Mtb-SecBTA under the control of an anhydrotetracycline inducible promoter was co-transformed with pC6-Mtb-HigBA1 and the pSE380-based vector (−),
luciferase (Luc), or the Luc-Mtb-ChAD and Luc-Mtb-ChADY114A chimeras. Transformants were grown to mid-log phase, serially diluted and spotted on LB
ampicillin chloramphenicol agar plates without or with IPTG (to express Luc and Luc chimeras), arabinose (to express Mtb-HigBA1), and
anhydrotetracycline (to express Mtb-SecBTA) inducers as indicated. Plates were incubated overnight at 37 °C
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-08747-4
10 NATURE COMMUNICATIONS |          (2019) 10:782 | https://doi.org/10.1038/s41467-019-08747-4 | www.nature.com/naturecommunications
an enthalpically and entropically favored binding (ΔH=−26.1
kJ mol−1 and −TΔS=−15.9 kJ mol−1) suggesting association to
the major groove of DNA42. The stoichiometry obtained by ITC
for this specific association is 1.1, consistent with a binding
involving one palindromic DNA sequence per Mtb-HigA1 dimer
present in the Mtb-SecBTA/HigA1 hetero-hexamer. Measuring
the temperature dependence of the enthalpy gave a negative heat
capacity of binding (−1.3 kJ mol−1 K−1) as typically reported for
the majority of sequence-specific protein/DNA associations43.
Together these results show that the highly unstable Mtb-HigA1
antitoxin can form a functional dimer following binding to its
specific chaperone partner.
It has been proposed that disrupting the TA interfaces by small
molecules or peptides to trigger endogenous toxin activation
in vivo could represent a novel antibacterial tool to induce
bacterial death from the inside44. The tripartite TAC system
significantly differs from classical two-component TA systems
due to the fact that the TAC antitoxin has acquired a C-terminal
ChAD segment, which efficiently triggers antitoxin aggregation
and/or degradation in the absence of chaperone, thus leading to
toxin activation. Therefore, we hypothesized that disrupting an
earlier step in the toxin inactivation pathway, namely the
interaction between the chaperone and its antitoxin client, might
lead to growth inhibition. To begin to approach this specific
point, we first used native MS experiments to investigate whether
a stably formed Mtb-SecBTA/HigA1 complex could be disrupted
in vitro by increasing concentrations of ChAD peptide. In the
absence of peptide, we mainly found 4:2 Mtb-SecBTA/HigA1
hetero-hexamers together with Mtb-SecBTA tetramers, with MW
of 114.9 and 81.6 kDa, respectively (Supplementary Fig. 9b).
Upon incubation with low amounts of ChAD, we observed
peptide binding to both tetrameric Mtb-SecBTA (as described
above) and to the Mtb-SecBTA/HigA1 hexamer (Supplementary
Fig. 9c, d). At higher peptide concentrations, more ChAD
peptides bound to the hexamer, leading to the progressive
dissociation of the tetramer from the complex (Fig. 5c and
Supplementary Fig. 9e, f). These results suggest that a preformed
antitoxin/chaperone complex in vivo might also be disrupted by
the presence of a ChAD competitor, thus leading to a free active
toxin and the subsequent inhibition of bacterial growth. To test
such a hypothesis, we constructed luciferase chimeras containing
a grafted C-terminal ChAD extension, either wild type or
carrying the Y114A mutant unable to interact with the chaperone,
overexpressed them in the presence of TAC and monitored
bacterial growth in our toxicity rescue assay (Fig. 5d). Remark-
ably, we found that expression of the luciferase chimera with
wild-type ChAD sequence could severely inhibit bacterial growth
in the presence of TAC, while the Y114A mutant or the luciferase
without ChAD could not. Together these results suggest that
Mtb-SecBTA/HigA1 complexes, with or without Mtb-HigB1
toxin, can be disrupted both in vitro and in vivo.
Discussion
In this work, we provide biophysical and structural insights
into the mechanism of chaperone addiction. We solved the high-
resolution crystal structure of a TA-associated chaperone bound
to the ChAD region of its antitoxin client. This structure
reveals major differences in binding mode when compared to
SecB–SecA or SecB-presecretory substrate complexes (Fig. 6)
and identifies major contact surface residues involved in the
chaperone–antitoxin interface.
The first structural report of a complex between SecB and a
partner protein was the 2.8 Å X-ray structure of Hi-SecB with the
C-terminal 27 residues of SecA (SecAc)8. In this structure, SecAc
adopts a totally different conformation than the one adopted by
the Mtb-HigA1 (104–116) region and binding to the Hi-SecB
chaperone occurs at a very different position with respect to the
tetramer (Fig. 6 and Supplementary Fig. 1a). In this case, there are
two bound SecAc peptides per Hi-SecB tetramer and each peptide
interacts with the acidic cluster found on the eight-stranded β-
sheet, resulting in a predominantly electrostatic interface8 (Fig. 1b
and Supplementary Fig. 3). More recently, a comprehensive NMR
analysis of the interaction between Ec-SecB and two different
secretory protein clients (namely PhoA and MBP) in the unfolded
state has been published6. The solution structure of the different
complexes shows how a single-protein client wraps around the
Ec-SecB tetrameric assembly and is in agreement with earlier
biochemical data showing that Ec-SecB can interact with long
stretches of unfolded protein substrates5,45. Here, we mainly refer
to the Ec-SecB–PhoA complex, which was the most thoroughly
analyzed in the NMR study (Supplementary Fig. 1a). In this case,
the client protein interacts through long unstructured hydro-
phobic segments that mostly fill the chaperone hydrophobic
grooves (Fig. 1b and Supplementary Fig. 3). Remarkably, our data
show that binding of PhoA precursor to Ec-SecB shares no
apparent similarity with binding of ChAD to Mtb-SecBTA.
Indeed, we found that the ChAD peptide binding sites on Mtb-
SecBTA run perpendicular with respect to the different PhoA
binding sites in Ec-SecB (Supplementary Fig. 10) and that only
few residues of Ec-SecB that interact with PhoA have counter-
parts in Mtb-SecBTA that interact with ChAD. Finally, although
some of these residues of the contact surface spatially overlap, the
interaction modes are significantly different (Fig. 1b). This is
especially true for the three W108, R110, and Y114 residues of
ChAD that are involved in strong interactions with Mtb-SecBTA
(Supplementary Fig. 11).
Analysis of the full-length Mtb-SecBTA/HigA1 complex shows
that the aggregation-prone antitoxin of TAC forms a dimer when
bound to the Mtb-SecBTA chaperone. The dimeric nature of the
chaperone-bound antitoxin is in agreement with the observation
that the chaperone-independent Mtb-HigA1 deleted of its C-
terminal ChAD region (Mtb-HigA1ΔC42) also forms a soluble
dimer and is functional in vivo in the absence of the chaperone
(this work and ref. 29). Such data strongly suggest that the
chaperone-bound antitoxin dimer could reach a functional form.
This is further supported by the fact that chaperone-bound Mtb-
HigA1 has the ability to bind to its native promoter region
in vitro and to inhibit the toxin in vivo. Whether such a con-
formation represents the fully folded antitoxin remains to be
determined. Although SecB chaperones mainly assist protein
export by preventing the folding of presecretory protein clients,
our data show that some SecB chaperones can also assist the
folding of cytosolic substrates such as the Mtb-HigA1 antitoxin.
This property is in agreement with the observation that over-
expressed Ec-SecB can partially rescue the bacterial growth defect
of an E. coli strain lacking both major cytosolic chaperones DnaK
and Trigger Factor, and that Ec-SecB can bind cytosolic proteins
co- and/or post-translationally in vitro46.
Our data also reveal that Mtb-SecBTA can potentially accom-
modate four ChAD peptides, although in this work we show that
only one Mtb-HigA1 dimer is bound to one Mtb-SecBTA tetra-
mer. Yet, the full-length ChAD region of Mtb-HigA1 contains a
second stretch of residues (137WARHISVR144) that is similar to
the first motif (108WHRLSSYR115) present in the ChAD peptide
used in this work. Since these motifs resemble the previously
identified SecB-binding motifs4, that they both contain at least the
key tryptophan and arginine residues involved in tight interaction
with the chaperone, and that they are separated by a stretch of
21 amino-acid residues, such additional segment might well
contribute to a secondary, lower affinity binding site. Note that in
this case, binding would require a structural rearrangement at the
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chaperone level to unlock steric constraints due to its distorted
dihedral symmetry. In addition, secondary binding events could
further increase the affinity of the antitoxin for the chaperone,
when compared to the peptide alone. On the other hand, these
two binding sites might stay readily accessible to other substrates
or partners, including SecA or presecretory proteins, suggesting
that they could also contribute to the activation cycle of the TAC
system in response to certain stress, as previously proposed1.
Methods
Bacterial strains and culture conditions. E. coli strains W3110 and W3110 secB::
CmR35 have been described. Bacteria were routinely grown in LB medium sup-
plemented when necessary with kanamycin (50 µg ml−1), chloramphenicol (15 µg
ml−1), or ampicillin (50 µg ml−1). For strain W3110 ΔaraBAD::PTet-Rv1957
(KanR) ΔsecB, named WPtet57, the chromosomal araBAD operon was replaced by
a cassette containing the Mtb-SecBTA under the control of an anhydrotetracycline
inducible promoter using recombineering technology47.
Plasmid constructs. Plasmids pMPMK648, p29SEN49, p29-Mtb-SecBTA30, pET-
Duet-6HISMtb-SecBTA-HigA1, pET15b-Mtb-SecBTA and pK6-Mtb-HigBA122, and
pET15b (Novagen) have been described. The p29-Mtb-SecBTA mutant derivatives
were constructed by QuickChange mutagenesis (Stratagene) using appropriate
primers (Supplementary Table 3) and p29-Mtb-SecBTA as DNA template. The
constructs were sequenced verified using appropriate primers. To construct
pET15b-Mtb-HigA1ΔC42, Mtb-higA1ΔC42 was PCR amplified with primers pBAD
FOR(5′-CGCAACTCTCTACTGTTTC-3′) and higA ΔC42 REV H/B (5′-TTTAA
GCTTGGATCCTCACGTAGGCACTTCGCGAAGCGTG-3′) and cloned as a
NdeI-BamHI fragment into pET15b vector. To construct plasmids pSE-Luc and
pSE-Luc-Mtb-ChAD, the EcoRI/HindIII digested fragments containing the Pho-
tinus pyralis luciferase gene, either WT or fused to the Mtb-HigA1 (ChAD) C-
terminal region22, were subcloned into EcoRI/HindIII digested pSE380ΔNcoI49.
Plasmid pSE-Luc-Mtb-ChAD was used as template to construct plasmid pSE-Luc-
Mtb-ChADY114A by QuickChange mutagenesis with higA1 ChAD codon change
TAT→GCC. To construct plasmid pC6-Mtb-higBA1, the EcoRV-SphI digested
Mtb-higBA1 fragment from pK6-Mtb-higBA1 was cloned into the chloramphenicol
resistant plasmid pBAD3350 digested with the same enzymes.
In vivo TA control by chaperones. Toxin inhibition assay in vivo was performed
as described22, except that Mtb-SecBTA and its mutant derivatives were cloned on
the low-copy plasmid p29SEN49. Briefly, fresh transformants of E. coli strains co-
expressing the p29SEN-based chaperone and the pMPMK6-based Mtb-HigBA1
pair under the control of the Ptrc and PBAD promoter, respectively, were grown in
LB ampicillin kanamycin to mid-log phase, serially diluted and spotted on LB
ampicillin kanamycin agar plates with or without IPTG (to induce the chaperone)
and arabinose (to induce Mtb-HigBA1) as indicated in the figure legends. Plates
were incubated overnight at 37 °C. When strain WPtet57 was used, 4 nM of
anhydrotetracycline was added to induce expression of Mtb-SecBTA.
In vivo chaperone assays. It was previously shown that E. coli secB mutants do
not grow at low temperature and are sensitive to novobiocin antibiotic30,34,35, likely
due to the intrinsic cold sensitive property of the Sec translocon and to an impaired
outer membrane1,51. In this case, it was found that growth at low temperature and
resistance to novobiocin requires a functional interaction between SecB and SecA
in vivo30,35. Complementation of SecB chaperone activity in vivo at 18 °C was
performed as follows. Fresh transformants of W3110 ΔsecB::CmR containing p29-
Mtb-SecBTA or its mutant derivatives were grown at 37 °C to mid-log phase in LB
ampicillin, serially diluted, and spotted on LB ampicillin agar plates in the absence
or presence of IPTG inducer. Plates were incubated at 37 °C overnight or for 3 days
at 18 °C. For novobiocin resistance, mid-log phase cultures of strain W3110 ΔsecB
containing p29-Mtb-SecBTA or its mutant derivatives in LB ampicillin were serially
diluted and spotted on LB ampicillin agar plate with 30 µg ml−1 novobiocin, and
incubated overnight at 37 °C.
Protein purification. Mtb-SecBTA with a N-terminal His6-tag was purified fol-
lowing overexpression in a BL21(λDE3) E. coli strain harboring plasmid pET15b-
Rv1957 as described22. The Mtb-SecBTA/HigA1 complex was overexpressed from
plasmid pDUET-1 transformed in BL21(λDE3) giving his-tagged Mtb-SecBTA and
untagged HigA1. For production, cells (500 ml) were grown at 30 °C to an OD600 of
0.5 in LB medium containing 100 µg ml−1 ampicillin, and expression of the protein
or the complex was induced with 1 mM IPTG for 3 h. Cells were harvested, washed
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in phosphate-buffered saline (PBS) buffer (pH 7.2), and stored at −80 °C. Cells
were thawed in lysis buffer (20 mM Tris, 2 mM EDTA, 2 mM DTT, 20 mM imi-
dazole, 100 mM NaCl, pH 7.5) containing 0.5 mg ml−1 lysozyme, sonicated on ice
using five intermittent pulses of 30 s, and centrifuged at 30,000 g for 45 min at 4 °C.
The supernatant was loaded onto a 1-ml HiTrap HP (GE Healthcare) FPLC col-
umn, pre-equilibrated in buffer A (20 mM Tris, 0.1 mM EDTA, 200 mM NaCl, pH
7.5) supplemented with 20 mM imidazole. The column was washed with buffer A
supplemented with 40 mM imidazole. Elution was achieved with buffer A sup-
plemented with 160 mM imidazole and the more concentrated fractions were
pooled. The pooled fractions containing Mtb-SecBTA (approximately 20 mg) or
Mtb-SecBTA/HigA1 (approximately 10 mg) were applied onto a HiLoad 16/60
Superdex 200 prep-grade column (GE Healthcare) pre-equilibrated with buffer GF
(20 mM MES, 200 mM NaCl, pH 6.5). Mtb-SecBTA eluted as two major peaks
characterized as octamer and tetramer using SEC-MALS experiments. Only the
fractions corresponding to the tetramer, which eluted at a volume of 72.5 ml, were
pooled and subjected to thrombin cleavage to remove the N-terminal His6-tag.
Mtb-SecBTA/HigA1 eluted as a major peak at 68.2 ml, which was further char-
acterized as a hetero-hexamer by SEC-MALS. Removal of the N-terminal His6-tag
on Mtb-SecBTA was performed by incubating the protein at 0.5 mg ml−1 in GF
buffer with thrombin under shaking for 3 h at room temperature. After checking by
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), the
cleaved sample was loaded on a HiTrap HP column pre-equilibrated in buffer A
supplemented with 20 mM imidazole to remove the tagged protein. Further pur-
ification by gel filtration in the conditions described above led to a single peak.
Finally, gel filtrated proteins were concentrated with Vivaspin 20 (10 kDa and 30
kDa cutoff for Mtb-SecBTA and Mtb-SecBTA/HigA1, respectively) and either
freshly used, for crystallization, or flash-frozen in liquid nitrogen and stored at
−20 °C while awaiting biophysical characterization.
Mtb-HigA1ΔC42 (Mtb-HigA1 deleted of the last 42 residues) was overexpressed
from pET15b-HigA1ΔC42 in BL21(λDE3) as a fusion protein containing a N-
terminal His6-tag. For production, cells (2 l) were grown to an OD600 of 0.6–0.7 in
LB medium containing 100 µg ml−1 ampicillin at 30 °C, and expression of theMtb-
HigA1ΔC42 was induced with 1 mM IPTG for 4 h. Cells were harvested, washed in
PBS buffer (pH 7.2), and stored at −80 °C. It is noteworthy that all buffers used for
purification of Mtb-HigA1ΔC42 contained 0.2 mM AEBSF. Cells were thawed in
lysis buffer containing lysozyme at 0.5 mg ml−1, sonicated on ice using five
intermittent pulses of 30 s, and centrifuged at 30,000 g for 45 min at 4 °C. The
supernatant was loaded onto a 1-ml HiTrap HP (GE Healthcare) FPLC column
pre-equilibrated in buffer A supplemented with 20 mM imidazole. Washing and
elution of the column were achieved with buffer A supplemented with 40 and
300 mM imidazole, respectively. Mtb-HigA1ΔC42-containing fractions were pooled
and concentrated on a Vivaspin 20 (10 kDa) and the recovered retentate applied
onto a Superdex 75 10/300 GL column (GE Healthcare) pre-equilibrated with
buffer GF. Fractions containing Mtb-HigA1ΔC42 appeared as a continuous elution
(ranging from 11 to 27 ml) confirmed using SDS-PAGE gel. Eluted fractions were
pooled, concentrated, flash-frozen and stored at −20 °C while awaiting biophysical
characterization.
Concentrations were determined by measuring UV absorption at 280 nm with a
NanoDrop 2000 spectrophotometer (ThermoScientific) and using calculated molar
extinction coefficients (in M−1 cm−1) of 15,930 for untagged Mtb-SecBTA (20,388
Da), 94,460 for untagged Mtb-SecBTA/HigA1 (considered as a hetero-hexamer of
115,068 Da in all calculations), and 2980 for tagged Mtb-HigA1ΔC42 (13,997 Da).
Crystallization and structure determination. The 13-mer ChAD peptide corre-
sponding to residues 104EVPTWHRLSSYRG116 of Mtb-HigA1 was synthesized by
Schafer-N (Copenhagen, Denmark) to >95% purity and solubilized in GF buffer.
Purified Mtb-SecBTA was concentrated to 30mgml−1 (1.5mM) in GF buffer and
mixtures of Mtb-SecBTA and ChAD peptide, supplemented or not with 5% of gly-
cerol, were subjected to crystallization trials performed at 285 K using the vapor
diffusion method in sitting drops. Final peptide concentrations were chosen to
reach a peptide/protein molar ratio of 3.0 starting from Mtb-SecBTA protein and
ChAD peptide (MW= 1588Da and calculated molar extinction coefficient of 6990
M−1 cm−1) stock solutions at 1.5 and 18.5mM, respectively. Drops consisting of 200
nL of complex and 200 nL of precipitant solution were equilibrated against 80 µL of
reservoir solution. Several crystallization conditions were obtained in the presence of
PEG of various molecular weights and additives such as calcium acetate, MgCl2, or
LiCl. The best diffracting crystals were grown with the protein in GF buffer supple-
mented with 5% glycerol and in the presence of 100mM Tris, 25–27% PEG 1500,
80–240mM calcium acetate, 10% DMSO, pH 8.0. They were directly frozen under a
cryogenic nitrogen stream and stored in liquid nitrogen before data collection at 100
K. Diffraction data were measured from tetragonal crystals diffracting to ca. 1.8 Å at
the ESRF synchrotron (Grenoble, France) on beamline ID29 using a PILATUS 6M
detector. X-ray images were indexed, integrated and scaled on-line using autoP-
ROC52. Programs from the CCP4 software suite53 were used for subsequent crys-
tallographic calculations54. The structure was determined by the molecular
replacement method with PHASER55 and a starting model derived from the structure
of SecB from H. influenzae31 (PDB code 1FX3). An initial model was automatically
built with Buccaneer56 and used as a starting point for iterative refinement with
Refmac57 and manual rebuilding using Coot58. Final refinement led to Rwork/Rfree
values of 0.212/0.265. Data collection and refinement statistics are given in Table 1.
Quality of the structure was validated during the PDB deposition process. Protein
structure databases were searched and structures were superimposed with Dali
software59,60 and SUPERPOSE from the CCP4 software package. Molecular interfaces
were explored using PISA calculations as implemented on the EMBL-EBI server61. All
structures and the electrostatic potential of protein surfaces were visualized with
PyMOL62. The sequence alignment was generated with ESPript 363.
MD calculations. The X-ray structure was used to generate a starting template of the
Mtb-SecBTA/ChAD complex after building missing residues of the chaperone
(Table 1), finally accounting for 161 residues from Asp6 to Met166. The tleap module
of Amber1464 was used to generate a periodic octahedral box containing the complex
extended by 10Å and filled with TIP3P water molecules and sodium ions to neu-
tralize the overall charge of the system. Energy minimization and MD simulation were
performed with the parallel version of the pmemd module of Amber14. After an
initial energy minimization with progressively reduced restraints on the position of all
atoms (excluding solvent), 100 ps MD were run with temperature varying linearly
from 0 to 300 K at constant volume, followed by a 400 ps MD at 300 K and a constant
pressure of 1 bar, with the atomic coordinates saved every 2 ps. Three MD simulations
of 20 ns were performed at a constant pressure of 1 bar, with atomic coordinates saved
every 10 ps. The corresponding trajectories were concatenated in order to build a 60
ns MD simulation. Distance and angle variations in the course of the simulation were
analyzed with the cpptraj module65 from Amber14.
Size-exclusion chromatography and multi-angle light scattering. Samples of
Mtb-SecBTA at 49.1 µM (1.0 mgml−1),Mtb-SecBTA/HigA1 at 6.5 µM (0.75mgml−1),
andMtb-HigA1ΔC42 at 100 µM (1.4mgml−1) in 20mMMES, 200mM NaCl, pH 6.5
were analyzed on a Superdex 200 Increase 5/150 (GE Healthcare) with multi-angle
light scattering. The column was equilibrated with the same buffer, previously ster-
ilized on a 0.1-µm filter, on an Agilent 1260 Infinity LC chromatographic system
(Agilent Technology). Data were collected on a DAWN HELEOS-II 8-angle and
Optilab T-rEX refractive index detector (Wyatt Technology, Toulouse, France). We
loaded 75–100 μl of each protein sample and separation was performed at a flow rate
of 0.4mlmin−1 at 15 °C. Results were analyzed with ASTRA 6.0.2.9 software (Wyatt
Technology Corp.).
SAXS experiments. SAXS experiments were conducted in HPLC mode on the
BM29 beamline at the ESRF synchrotron, Grenoble, France. Mtb-SecBTA (40 µl at
474 µM and 50 µl at 879 µM), Mtb-SecBTA/HigA1 (60 µl at 136.5 µM) samples in
20 mM MES, 200 mM NaCl, pH 6.5 were injected onto a Superdex 200 Increase 5/
150 column, equilibrated with the same buffer supplemented with 2 mM DTT, and
run at 0.3 ml min−1 and a temperature of 15 °C. Mtb-SecBTA was also measured in
the presence of the ChAD peptide at a protein:peptide molar ratio of 6:4 (50 µl at
881 µM protein and 588 µM peptide) and the column was equilibrated in the same
buffer supplemented with 200 µM of ChAD peptide. Data were collected in a Q
range of 0.035–4.9 nm−1, where Q= 4πsinθ/λ, with a scattering angle of 2θ. A total
of 780 frames of 1 ms each were collected throughout the whole elution time. Data,
displayed on an absolute scale using water calibration, were processed with the
ATSAS suite66. After buffer subtraction, Guinier analysis at low Q was performed
on each curve using the PRIMUS program to check for the stability of the asso-
ciated radius of gyration, and the selected frames were averaged. Molecular weights
were determined using the concentration-independent method36 and Guinier
analysis using PRIMUS within the limit Q.Rg < 1. Regularized indirect transforms
of the scattering data were performed with the program GNOM to obtain P(r)
functions of interatomic distances.
Microscale thermophoresis. MST assays were carried out on a NanoTemper
Monolith NT.115 instrument (NanoTemper Technologies GmbH, Germany). Briefly,
Mtb-SecBTA at a concentration of 7.5 µM was labeled with the RED fluorescence dye
NT-647 according to manufacturer’s protocol in 20mM MES, 200mM NaCl, 5%
DMSO, pH 6.5. Labeling and removal of free dye were performed within 45min.
Subsequently, 100 nM of NT-647-labeled protein was mixed with various con-
centrations of ChAD peptide (3 nM to 100 µM) in 20mM MES, 200mM NaCl,
0.025% Tween 20, pH 6.5. After incubation for 5min at room temperature, 20 μl of
the mixtures were loaded into premium coated capillaries and MST data were col-
lected at 22 °C under 40% infrared laser power and 50% light-emitting diode power.
NanoTemper analysis software (2.1.2) was used to fit the independent experimental
data and determine dissociation constants (Kd) and associated errors.
Isothermal titration calorimetry. ITC experiments were carried out at 12 °C on a
MicroCal ITC200 system (Malvern Instruments) with purified Mtb-SecBTA and
ChAD peptide in 20 mM MES, 200 mM NaCl, pH 6.5. The titration protocol
comprised a preliminary 0.4 µl injection followed by 19 (resp. 39) consecutive
injections of 2 µl (resp. 1 µl) of peptide solution into the sample cell containing the
protein. Spacing between each injection was 180 s. Control titrations of peptide
solution into the protein-free experimental buffer were also performed. Data were
analyzed with MicroCal Origin 5.0 software on the basis of a “one set of sites”
which gave the best fit to experimental data. Thermodynamic parameters and
errors were obtained from four measurement repeats with concentrations in the
range 18–48 µM and 80–620 µM for the protein and the peptide, respectively.
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DNA binding assays using SEC-MALS and ITC. The 38-bp specific DNA duplex
used for SEC-MALS and ITC (5′-TAGCTGGGCATATAGGTTACAGCCTA-
TATTCTGGTATA-3′ and its complementary strand) was synthesized and HPLC-
purified by Sigma-Aldrich. The two complementary oligonucleotides were solubilized
in water and hybridized by heating to 98 °C followed by cooling, and the resulting
DNA duplex was then lyophilized (Alpha 1–2 LDplus, Christ). The powder was then
suspended in 20mM MES, 200mM NaCl, pH 6.5 at a concentration of 800 µM. For
SEC-MALS experiments, the 38-bp dsDNA oligomer (190 µM) was mixed with
purified Mtb-SecBTA/HigA1 (23.5 µM) in the same buffer, at a DNA/protein molar
ratio of 1.28, followed by a 5-min incubation at 4 °C. The DNA–protein sample
(51 µg) was then injected at 18 °C. For ITC experiments, the 38-bp dsDNA oligomer
(170–190 µM) was used for titration into purified Mtb-SecBTA/HigA1 (18–23.5 µM)
at 12, 18, and 25 °C. Both SEC-MALS and ITC experiments were conducted using the
same experimental conditions as described above.
Native MS. Prior to native MS analysis, Mtb-SecBTA, Mtb-SecBTA/HigA1, and
Mtb-SecBTA/HigA1/DNA samples were desalted in 200 mM ammonium acetate,
pH 7 using Micro Bio-Spin devices (Bio-Rad, Marnes-la-Coquette, France) at
molar concentrations of 11.8 µM (tetramer), 9.7 (hexamer), and 10.5 µM (hepta-
mer), respectively. ChAD peptide stock solutions were prepared in the same buffer
at a final concentration of 10.9 mM. ChAD peptide/Mtb-SecBTA molar ratios were
from 0 to 20, corresponding to peptide concentrations ranging from 0 to 195 µM
and a maximum of 20 peptide molecules per chaperone tetramer. For the inter-
action with Mtb-SecBTA/HigA1, molar ratios were chosen to cover a range from 0
to 16 peptide molecules per hexamer. The 13-mer C2, C3, and C7 peptides (see
ref. 29) used as controls were prepared from concentrated stock solutions in water
and diluted 100-fold in the ammonium acetate buffer to a final concentration of
112.5 µM and injected in the presence of Mtb-SecBTA at a ratio of 8 peptides per
tetramer. All peptides were added to the chaperone or the chaperone–antitoxin
complex right before injection. Samples were analyzed on a SYNAPT G2-Si mass
spectrometer (Waters, Manchester, UK) running in positive ion mode and coupled
to an automated chip-based nano-electrospray source (Triversa Nanomate, Advion
Biosciences, Ithaca, NY, USA). The voltage applied to the chip and the cone voltage
were set to 1.6 kV and 150 V, respectively. The instrument was calibrated with a 2
mgml−1 cesium iodide solution in 50% isopropanol. Raw data were acquired with
MassLynx 4.1 (Waters, Manchester, UK) and deconvoluted with UniDec67 using
the following parameters: m/z range: 4000–8000 Th; subtract curved: 5; Gaussian
smoothing: 10; bin every 10 Th; charge range: 10–30; mass range: 80,000–125,000
Da; sample mass: every 10 Da; peak FWHM: 10 Th; peak detection range: 250 Da,
and peak detection threshold: 0.02–0.1. Kd values were obtained by fitting titration
curves in the data collector utility from Unidec with the following parameters:
“How to extract”: Local Max, “Number of proteins”: 1 (tetrameric concentration),
“Number of Ligands”: 4, “Protein and Ligand Models”: All KD’s Free, “Binding
Sites Per Proteins”: 4.
Hydrogen–deuterium exchange coupled to MS. Automated Hydrogen–Deuter-
ium eXchange coupled to MS (HDX-MS) experiments were performed on a
Synapt G2-Si mass spectrometer (Waters Scientific, Manchester, UK) coupled to a
Twin HTS PAL dispensing and labeling robot (LEAP Technologies, Carborro, NC,
USA) via a NanoAcquity system with HDX technology (Waters, Manchester, UK).
Briefly, 5.2 µL of protein at 15 µM were diluted in 98.8 µL of protonated (for
peptide mapping) or deuterated buffer (20 mM MES pD 6.5, 200 mM NaCl) and
incubated at 20 °C for 0, 0.5, 5, 10, and 30 min. Totally, 99 µL were then transferred
to vials containing 11 µL of pre-cooled quenching solution (500 mM glycine at pH
2.3). After 30 s quench, 105 µL were injected to a 100 µL loop. Proteins were
digested on-line with a 2.1 mm × 30mm EnzymateTM BEH Pepsin column (Waters
Scientific, Manchester, UK). Peptides were desalted for 2 min on a C18 pre-column
(Acquity UPLC BEH 1.7 µm, VANGUARD) and separated on a C18 column
(Acquity UPLC BEH 1.7 µm, 1.0 × 100 mm) by a linear gradient (2–40% acetoni-
trile in 13 min). Experiments were run in duplicates and protonated buffer was
injected between each duplicate to wash the column and avoid cross-over con-
tamination. Starting concentrations were 35 µM for Mtb-SecBTA alone and in the
presence of 8 molar equivalent of ChAD peptide (280 µM) and 18 µM for Mtb-
SecBTA/HigA1. Peptide identification was performed with ProteinLynx Global
SERVER (PLGS, Waters, Manchester, UK) based on the MSE data acquired on the
nondeuterated samples. Peptides were filtered in DynamX 3.0 with the following
parameters: peptides identified in at least 3 out of 5 acquisitions, 0.3 fragments per
amino-acid, intensity threshold 1000.
Data availability
The atomic coordinates and structure factors have been deposited in the Protein Data
Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New
Brunswick, NJ (code 5MTW). The HDX-MS and native MS data are available as files
Supplementary Data 1 and Supplementary Data 2, respectively. The source data
underlying Figs. 4b, d, e and 5c are provided as a Source Data file. Other data that
support the findings of this study are available from the corresponding authors on
request.
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